PT - JOURNAL ARTICLE AU - Bellinzona, Greta AU - Petazzoni, Greta AU - Merla, Cristina AU - Corbella, Marta AU - Samuelsen, Ørjan AU - Corander, Jukka AU - Sassera, Davide AU - Gaiarsa, Stefano AU - Cambieri, Patrizia TI - The COVID-19 pandemic sparked off a large-scale outbreak of carbapenem-resistant <em>Acinetobacter baumannii</em> from the endemic strains of an Italian hospital AID - 10.1101/2022.06.28.22276851 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.28.22276851 4099 - http://medrxiv.org/content/early/2022/06/28/2022.06.28.22276851.short 4100 - http://medrxiv.org/content/early/2022/06/28/2022.06.28.22276851.full AB - Acinetobacter baumannii is an insidious nosocomial pathogen that poses a serious threat due to the rise of incidence of multidrug resistant (MDR) strains. During the COVID-19 pandemic, MDR A.baumannii clones have caused several outbreaks worldwide. Here we describe a detailed investigation of an MDR A. baumannii outbreak that occurred at Fondazione IRCCS Policlinico San Matteo (Pavia, Italy). A total of 96 A. baumannii strains, isolated between January and July 2020 from 41 inpatients (both SARS-CoV-2 positive and negative) in different wards, were characterized by phenotypic and genomic analyses combining Illumina and Nanopore sequencing. Antibiotic susceptibility testing revealed that all isolates were resistant to carbapenems and the sequence analysis attributed this to the carbapenemase gene blaOXA-23. Screening of virulence factors unveiled that all strains carried determinants for biofilm formation. A core genome-based phylogeny was inferred to integrate outbreak strain genomes with background genomes from public databases and the local surveillance program. All strains belonged to the globally disseminated ST2 clone and were divided into two main clades. Strains from the outbreak clustered with surveillance isolates from 2019, suggesting that the outbreak was caused by two strains that were already circulating in the hospital before the start of the pandemic. The intensive spread of A. baumannii in the hospital was enhanced by the extreme emergency situation of the first COVID-19 pandemic wave that resulted in minor attention to infection prevention and control practices.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the ERC grant 742158 (Corander) Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Fondazione IRCCS Policlinico San Matteo (Pavia, Italy) gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors